14-3-3 family members are dimeric phosphoserine-binding proteins that parti
cipate in signal transduction and checkpoint control pathways. In this work
, dominant-negative mutant forms of 14-3-3 were used to disrupt 14-3-3 func
tion in cultured cells and in transgenic animals. Transfection of cultured
fibroblasts with the R56A and R60A double mutant form of 14-3-3 zeta (DN-14
-3-3 zeta) inhibited serum-stimulated ERK MAPK activation, but increased th
e basal activation of JNK1 and p38 MAPK. Fibroblasts transfected with DN-14
-3-3 zeta exhibited markedly increased apoptosis in response to UVC irradia
tion that was blocked by pretreatment with a p38 MAPK inhibitor, SB202190.
Targeted expression of DN-14-3-3 eta to murine postnatal cardiac tissue inc
reased the basal activation of JNK1 and p38 MAPK, and affected the ability
of mice to compensate for pressure overload, which resulted in increased mo
rtality, dilated cardiomyopathy and massive cardiomyocyte apoptosis. These
results demonstrate that a primary function of mammalian 14-3-3 proteins is
to inhibit apoptosis.